Abdulwhab Shremo Msdi
Overview
Explore the profile of Abdulwhab Shremo Msdi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
2
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shremo Msdi A, Haghparast A, Garey K, Wang E
Nutrients
. 2025 Mar;
17(5).
PMID: 40077695
The purpose of this scoping review was to provide a comprehensive understanding of the current knowledge concerning the gut microbiome and SCFAs as emerging treatments for salt-sensitive hypertension. Relevant animal...
2.
Shremo Msdi A, Ravari A, Abdul-Mutakabbir J, Tan K
Infect Dis Ther
. 2025 Feb;
PMID: 39962022
Introduction: This study compared the calculated vancomycin area under the curve (AUC) using trapezoidal and non-trapezoidal first-order pharmacokinetic equations. Methods: This retrospective observational study included adult patients with documented MRSA...
3.
Shremo Msdi A, Abdul-Mutakabbir J, Tan K
Infect Dis Ther
. 2024 Jun;
13(8):1807-1819.
PMID: 38922527
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious threat to public health. Vancomycin (VAN) remains the primary treatment for these infections, and achieving the recommended area under the curve...
4.
Giacoletti G, Price T, Hoelz L, Shremo Msdi A, Cossin S, Vazquez-Falto K, et al.
Front Pharmacol
. 2022 Jul;
13:935588.
PMID: 35899113
Among the ten different adenylyl cyclase isoforms, studies with knockout animals indicate that inhibition of AC1 can relieve pain and reduce behaviors linked to opioid dependence. We previously identified ST034307...